The FDA says it wants to level the playing field by having generic drugmakers independently update drug labels when there are known risks to the products. The industry feels as if it is being nudged ...

The FDA’s new proposal would level the playing field, but the Generic Pharmaceutical Association is skeptical -- according to a study they sponsored, the proposed requirements would inflate the cost ...

WASHINGTON, Feb 28 (Reuters) - Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive ...

Canada's two biggest generic drug makers are threatening to stop making new investments in the country if the federal government adopts new food and drug regulations that handicap their efforts to ...